ArticlePloS one2014

The potent Cdc7-Dbf4 (DDK) kinase inhibitor XL413 has limited activity in many cancer cell lines and discovery of potential new DDK inhibitor scaffolds.

Nanda Kumar Sasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.